Lundbeck
HLUN-B.CO
#2699
Rank
HK$50.31 B
Marketcap
HK$53.01
Share price
0.94%
Change (1 day)
15.47%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): HK$6.66 Billion

According to Lundbeck's latest financial reports the company's current earnings are HK$3.61 Billion. In 2024 the company made an earning of HK$4.32 Billion, an increase over its 2023 earnings that were of HK$3.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$6.66 B53.93%
2024 HK$4.32 B25.74%
2023 HK$3.44 B21.77%
2022 HK$2.82 B31.57%
2021 HK$2.14 B-4.61%
2020 HK$2.25 B-45.06%
2019 HK$4.09 B-34.04%
2018 HK$6.21 B12.83%
2017 HK$5.50 B93.99%
2016 HK$2.83 B-137.28%
2015 -HK$7.62 Billion-1246.24%
2014 HK$0.66 B-72.36%
2013 HK$2.40 B4.38%
2012 HK$2.30 B-55.18%
2011 HK$5.13 B5.65%
2010 HK$4.86 B-5.9%
2009 HK$5.16 B